CRO

TFF Pharmaceuticals Announces Program Updates for Voriconazole Inhaled Powder and Tacrolimus Inhaled Powder Clinical Programs

Retrieved on: 
Tuesday, November 1, 2022
Annual report, Inhalation, Acquisition, Toxicity, CRO, Nose, Lung, GLOBE, Risk, Freezing, Absorption, Powder, Safety, Government, Technology, Vaccine, NASDAQ, Company, FDA, Skin, Patient, TFF, Therapy, Pharmaceutical industry

FORT WORTH, Texas, Nov. 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc.(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced program updates for Voriconazole Inhaled Powder (TFF VORI) and Tacrolimus Inhaled Powder (TFF TAC) clinical programs.

Key Points: 
  • FORT WORTH, Texas, Nov. 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc.(NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced program updates for Voriconazole Inhaled Powder (TFF VORI) and Tacrolimus Inhaled Powder (TFF TAC) clinical programs.
  • We have taken a hands-on approach to assist our clinical sites that have managed issues related to staffing shortages within the healthcare system.
  • We have addressed protracted global supply chain issues that impeded the acquisition of the comparator drug for the TFF VORI trial.
  • TFF Pharmaceuticals proprietary Thin Film Freezing (TFF) technology allows for the transformation of both existing compounds and new chemical entities into dry powder formulations exhibiting unique characteristics and benefits.

Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer

Retrieved on: 
Tuesday, November 1, 2022
OEM, Marketing, Failure, Growth, CEO, Knowledge, CRO, Leadership, SEC, Income, GLOBE, Research, Public expenditure, Government, Education, FDA, HEC, EEG, Neurology, Association, Forward-looking statement, Projection, OTCQB, Medical imaging, Risk management, Brain

Cloutier will lead Brain Scientifics sales and marketing strategy, leveraging his experience in direct and indirect sales channels and deep relationships across distributors, research institutions and regulators in the medical technology space.

Key Points: 
  • Cloutier will lead Brain Scientifics sales and marketing strategy, leveraging his experience in direct and indirect sales channels and deep relationships across distributors, research institutions and regulators in the medical technology space.
  • Daniels decades of leadership are crucial at this juncture for Brain Scientific to continue accelerating its path to revenue, said Hassan Kotob, chairman and CEO of Brain Scientific.
  • With a growing number of opportunities and partners, Brain Scientific is poised for rapid growth in the immediate future.
  • Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices.

Bishop Fox adds Former Palo Alto Networks and RSA Senior Executive as Chief Revenue Officer

Retrieved on: 
Tuesday, November 1, 2022
Cortex, Growth, CRO, GLOBE, Series, Technology, Industry, Red Hat, Global Accounting Alliance, RSA Security, VP, Solution, Hunting, Video game, Cosmos

PHOENIX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bishop Fox, the leading authority in offensive security, today announced the addition of Brian de Lemos as the company’s new Chief Revenue Officer (CRO).  Most recently VP of Global Sales for Palo Alto Networks Unit 42, de Lemos holds more than 20 years of experience in leading global security organizations and driving growth. de Lemos will report to Bishop Fox CEO, Vinnie Liu.

Key Points: 
  • PHOENIX, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bishop Fox , the leading authority in offensive security, today announced the addition of Brian de Lemos as the companys new Chief Revenue Officer (CRO).
  • Most recently VP of Global Sales for Palo Alto Networks Unit 42, de Lemos holds more than 20 years of experience in leading global security organizations and driving growth.
  • de Lemos will report to Bishop Fox CEO, Vinnie Liu.
  • Bishop Fox has always had a great reputation in the industry, and seeing it up close has exceeded my expectations, said de Lemos.

Pharma R&D Outsourcing Global Market Report 2022: Paradigm Shift Towards Virtual Clinical Trials Reshaping Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 2, 2022
Pharmaceutical, Health, Clinical Trials, Virtual, BASF, CRO, Merck, Cros, J&J, Research, Time, Disease, Immunotherapy, AI, Safety, Decision-making, Technology, Artificial intelligence, University of Cambridge, University, Cambridge University Hospitals NHS Foundation Trust, USD, Genetic engineering, Novartis, AstraZeneca, Machine learning, Patient, Contract research organization, LEO, MD Anderson Cancer Center, Drug development, Biotechnology, Drug discovery, Solution, Fine chemical, Medical device, Pharmaceutical industry, Bayer

The "Pharma R&D Outsourcing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Pharma R&D Outsourcing Market - Global Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The pharmaceutical R&D outsourcing market is expected to grow as pharmaceutical and biotechnology companies spend more on outsourced services.
  • Virtual clinical trials or decentralized clinical trials can bring significant digital changes to clinical research methods and enhance the patient-centric ecosystem.
  • However, a complete digital or cross model of patient enrolment is employed in decentralized clinical trials.

TOTUS Welcomes Eric Thiegs as Senior Vice President of Strategic Partnerships

Retrieved on: 
Wednesday, November 2, 2022
Professional Services, Marketing, Retail, Communications, Other Retail, Finance, API, Marketing, Growth, CEO, Acquisition, Strategic partnership, CRO, Organization, Industry, Love, NGC, POS, Reward, Multimedia, Senior, Blackhawk Network Holdings, Solution, Online shopping, Cryptocurrency

TOTUS Gift Card Management, a rapidly growing company chartered to provide gift card issuance and comprehensive program management solutions for brands, has named Eric Thiegs as Senior Vice President of Strategic Partnerships.

Key Points: 
  • TOTUS Gift Card Management, a rapidly growing company chartered to provide gift card issuance and comprehensive program management solutions for brands, has named Eric Thiegs as Senior Vice President of Strategic Partnerships.
  • View the full release here: https://www.businesswire.com/news/home/20221102005554/en/
    Eric Thiegs - TOTUS SVP of Strategic Partnerships (Photo: Business Wire)
    Prior to joining the TOTUS team, Thiegs formally served as the CRO for NGC (National Gift Card) and as one of its Partners on the board.
  • Most recently, after NGCs acquisition by Blackhawk Network in 2020, Thiegs joined Flexa, the worlds first pure digital currency payments network, as its Head of Partnerships.
  • Eric is indisputably one of the most well-respected professionals in this industry, said Dave Jones, CEO of TOTUS Gift Card Management.

Ermetic Appoints Scott Hoard Head of Global Channel Sales

Retrieved on: 
Wednesday, November 2, 2022
Professional Services, Security, Technology, Software, Consulting, Networks, Cloud, Google Cloud Platform, Imperva, Knowledge, Software as a service, CRO, Central Michigan University, Micro ISV, Norwest Venture Partners, Internet, Palo Alto Networks, Microsoft, A10 Networks, Barracuda Networks, Technology, GCP, AWS, CSPM, Area, Solution, Consultant, Azure, Video game console, Facebook, Accel, Ermete Stampa

Ermetic , the cloud infrastructure security company, today announced that Scott Hoard is the companys new Head of Global Channel Sales, and will manage the Ermetic Synergia Partner Program for IT service providers, systems integrators, consultants, MSPs/MSSPs and ISVs.

Key Points: 
  • Ermetic , the cloud infrastructure security company, today announced that Scott Hoard is the companys new Head of Global Channel Sales, and will manage the Ermetic Synergia Partner Program for IT service providers, systems integrators, consultants, MSPs/MSSPs and ISVs.
  • Scott has served in senior channel roles with Fortanix, Corelight, Kenna Security, A10 Networks, Barracuda Networks and Imperva.
  • Scott is a results-oriented channel leader who has built and managed successful partner programs for several large security vendors, said Toby Buschinni, CRO of Ermetic.
  • Scott Hoard joins Ermetic from Fortanix where he served Area Vice President of Americas Channels, and developed and led the companys Fortanix Partners First program.

Barry Mirrer, Head of Quality Assurance, PROMETRIKA Has Earned CIPP/E Certification

Retrieved on: 
Wednesday, November 2, 2022
Online Privacy, Technology, Research, Security, Clinical Trials, Biotechnology, Health, Pharmaceutical, Science, International Association, ANSI, National data protection authority, CRO, Trust, CIPP, Organization, Clinical trial, International Association of Privacy Professionals, Industry, Program, Certification, Data management, Quality assurance, Privacy, Terminology, IAPP, Louise Mirrer, FDA, Information privacy, Biostatistics, Medical device

Barry Mirrer, Head of Quality Assurance, PROMETRIKA, has earned the ANSI-accredited Certified Information Privacy Professional/Europe (CIPP/E) credential through the International Association of Privacy Professionals (IAPP).

Key Points: 
  • Barry Mirrer, Head of Quality Assurance, PROMETRIKA, has earned the ANSI-accredited Certified Information Privacy Professional/Europe (CIPP/E) credential through the International Association of Privacy Professionals (IAPP).
  • Besides his Quality Assurance responsibilities, he serves as the Data Protection Officer for PROMETRIKA.
  • IAPP privacy certification is internationally recognized as a reputable, independent program that professionals seek and employers demand.
  • We are proud of Barry for completing certification in European privacy regulations and look forward to his continuing oversight of privacy and data protection efforts here at PROMETRIKA, Miganush Stepanians, Ph.D.

H.I.G. Capital Completes Sale of Taconic Biosciences

Retrieved on: 
Tuesday, November 1, 2022
Research, Finance, Professional Services, Biotechnology, Health, Pharmaceutical, Other Science, Other Professional Services, Science, Whitehorse, BDC, Growth, Taconic Biosciences, Perella Weinberg Partners, Avista Capital Partners, CRO, Partnership, H.I.G. Capital, Research, Gemstone, CLO, Sale, Investment, Company, Neurology, Association, Biotechnology, Financial services, Fine chemical, Risk management, Taconic

), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce the sale of its portfolio company Taconic Biosciences (Taconic or the Company) to Avista Capital Partners (Avista).

Key Points: 
  • ), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce the sale of its portfolio company Taconic Biosciences (Taconic or the Company) to Avista Capital Partners (Avista).
  • The Taconic team benefited from H.I.G.s support and partnership as we worked to achieve our shared growth goals and strategic mission.
  • Taconic has established itself as a market leader and is well positioned for continued growth under its new sponsor Avista.
  • Taconic Biosciences, Inc. is one of the worlds leading suppliers of murine research models for pharmaceutical, biotechnology, CRO, and academic research clients.

QHP Capital Forms Continuation Vehicle for Catalyst Clinical Research

Retrieved on: 
Tuesday, November 1, 2022
General Health, Professional Services, Health, Finance, Growth, CRO, Ropes & Gray, Partnership, Capital, Chapter, Leadership, Ownership, Partner, Technology, QHP, Company, FSP, Solution, Financial services, Fine chemical, Catalysis

QHP Capital L.P. ("QHP"), a Raleigh-based private equity firm which manages the NovaQuest Private Equity family of funds, today announced a single asset continuation fund (the Catalyst SPV) backing Catalyst Clinical Research LLC ("Catalyst" or the "Company"), a global contract research organization (CRO), providing full-service clinical development support for oncology-focused biotechs.

Key Points: 
  • QHP Capital L.P. ("QHP"), a Raleigh-based private equity firm which manages the NovaQuest Private Equity family of funds, today announced a single asset continuation fund (the Catalyst SPV) backing Catalyst Clinical Research LLC ("Catalyst" or the "Company"), a global contract research organization (CRO), providing full-service clinical development support for oncology-focused biotechs.
  • QHP originally invested in Catalyst in October 2018 through NovaQuest Private Equity Fund I, L.P. ("Fund I").
  • As part of a buy-and-build strategy, QHP and Catalyst have made four add-on acquisitions, creating a full-service, oncology-focused CRO (Catalyst Oncology) operating alongside the legacy FSP services now marketed as Catalyst Flex.
  • Catalyst is a clinical development organization providing highly customizable clinical research solutions to the global biopharmaceutical industry through two established solutions: Catalyst Flex and Catalyst Oncology.

Kantata Appoints JD Miller as Chief Revenue Officer

Retrieved on: 
Tuesday, November 1, 2022
Professional Services, Data Management, Other Professional Services, Technology, Software, Fintech, Internet, Cloud, Growth, Research Park at the University of Illinois Urbana-Champaign, EBITDA, CEO, Software as a service, Knowledge, Motus, CRO, Leadership, Organization, Salesforce, Board, Georgia Department of Community Supervision, Cloud computing, Advisory board, Department, Crain's Chicago Business, Friends, Miller, Technology, University, Doctor of Philosophy, Champaign County, Illinois, The Advisory Board Company, Communication, ARR, LGBTQ, Notability, Solution, JD, Fine chemical, Management

Kantata , the leading global supplier of purpose-built technology for professional services, has named JD Miller the companys new Chief Revenue Officer (CRO).

Key Points: 
  • Kantata , the leading global supplier of purpose-built technology for professional services, has named JD Miller the companys new Chief Revenue Officer (CRO).
  • Miller brings over 20 years of sales experience with valuable insights into cloud computing, enterprise technologies, and workforce solutions.
  • Prior to joining Kantata, Miller served as CRO at Motus, a Boston-based reimbursement solutions provider for the mobile workforce in the fleet industry.
  • JDs extensive experience and proven track record growing vertical SaaS businesses bring immediate impact to Kantata and will help extend our leadership position in the market," said Michael Speranza, CEO at Kantata.